This examine presents the case of a Metropolitan Municipality in the Aegean Region of Turkey, which undertook a sequence of initiatives to conduct initiatives on environmental safety and sustainability. This case examine was carried out as two separate research as a component of Horizon 2020-funded ECHOES mission underneath Work Package 6, aiming to achieve perception into the collective magnitudes of energy-related selections and conduct. The place to begin of the course of is marked, in 2015, by the municipality turning into a celebration to the Covenant of Mayors motion, becoming a member of round 8,000 signatories from over 50 international locations.
In line with European Union’s (EU’s) local weather targets and related energy-related insurance policies, signatories of the Covenant of Mayors goal to lower carbon emissions by 20% by 2020 and by 40% by 2030. In order to reinforce the design and operationalization of insurance policies for attaining these targets, every accomplice in the Covenant of Mayors is required to develop a Sustainable Energy Action Plan (SEAP). The SEAP is to be ready inside 2 years of turning into a celebration to the Covenant of Mayors and entails motion plans and initiatives in order to operationalize the methods for attaining the related targets.
To this finish, this examine analyzes the Metropolitan Municipality’s SEAP and its parts, which embody zero-emission public transportation mission, transformation of present buildings to a extra energy-efficient commonplace and associated vitality audit research, a mission for lowering ready intervals in visitors through a Smart Traffic System, a pedestrianization mission, and a mission for rising the use of geothermal vitality for district heating.
This examine got down to determine the inner and exterior components, in addition to bottom-up and top-down mechanisms concerned in numerous phases of the preparation and implementation of the SEAP. The analysis methodology was knowledgeable interviews, incorporating viewpoints and perceptions of stakeholders from totally different ranges of the municipality. Among the key outcomes are understanding the roles of fanatics and frontrunners in such initiative and the significance of top-management and central authorities assist.
Seroprevalence and molecular detection of Leishmania spp. in cats of West Aegean Region, Turkey
Zoonotic visceral leishmaniasis is attributable to protozoa of the genus Leishmania. Although canines are thought-about to be major reservoir hosts of Leishmania spp., a number of mammals, corresponding to foxes, jackals and small rodents may be hosts of totally different Leishmania spp. Previously, cats have been thought-about as asymptomatic hosts of the parasite with out appearing as a reservoir. In latest years, there was an rising quantity of leishmaniasis circumstances in cats, particularly in areas the place the an infection endemically happens. This knowledge point out that cats usually tend to be one of the fundamental reservoirs of Leishmania spp. relatively than being a non-reservoir host.
The goal of this examine is to find out the prevalence of Leishmania spp. by molecular and serological methods amongst owned and stray cats in 4 totally different cities situated in western half of Turkey. A whole of 386 blood and 301 serum samples have been collected from cats in Western Turkey the place leishmaniasis is endemic. Feline serum samples have been examined by IFAT to detect IgG antibodies towards Leishmania spp. antigens. Blood samples collected from 386 cats have been examined by PCR for the presence of Leishmania spp. According to PCR outcomes utilizing RV1/RV2 primers, 9 (2.3%) out of 386 samples have been optimistic for Leishmania spp.
Further PCR evaluation utilizing MC1/MC2 primers confirmed that one cat in Izmir was discovered to be contaminated with L. infantum/donovani complicated. Sequence evaluation revealed the presence of L. infantum, L. main and L. tropica amongst sampled cats in western half of Turkey. On the different hand, IFAT outcomes indicated that an total of 47 out of 301 (15.6%) cats that examined by PCR have been discovered to have anti-Leishmania anti bodies. Also, six of the seropositive cats have been owned animals. The current examine demonstrated that each owned and stray cats will be contaminated with Leishmania spp. and could be potential reservoirs for different animals and people.
Therefore, all communities residing in or close by endemic areas ought to be made conscious of the function of cats as potential reservoirs of an infection. In endemic areas, all animals ought to be protected towards an infection with pesticides and monitored routinely to manage the unfold of zoonotic visceral leishmaniasis.
Effect of East Asian atmospheric particulate matter deposition on bacterial exercise and neighborhood construction in the oligotrophic Northwest Pacific
Large quantities of anthropogenic East Asian (EA) particulate issues (PM), containing inorganic vitamins and natural matter, are deposited in the oligotrophic Northwest Pacific Ocean. However, the results of such deposition on marine microbes stay unclear. In this examine, the impact of EA PM deposition on marine micro organism was assessed by 5 on-board microcosm experiments, carried out in oligotrophic basins of the South China Sea. The addition of EA PM to the sampling water induced a transparent shift in bacterial neighborhood composition from prevailing oligotrophs (i.e., SAR 11 clade, Prochlorococcus, AEGEAN-169 marine group) to much less widespread copiotrophs (i.e., Alteromonas, Ruegeria, Flavobacteriaceae) and thus a slight improve in bacterial range.
The shift to extra energetic neighborhood composition, in addition to stimulation of PM vitamins, resulted in a big improve in cell-specific and bulk bacterial manufacturing. In distinction, there have been solely minor modifications in bacterial abundance, presumably because of elevated top-down mortality. The EA PM additionally exhibited a stronge poisonous impact on pico-cyanobacteria, resulting in a big lower in their proportion. Moreover, the responses of bacterial metabolism and neighborhood composition exhibited vital relationships with the hydrographic situation of the areas.
Genorise® recombinant mouse IL-15 protein |
|||
GR124211 | Genorise Scientific | 5 µg | 285 EUR |
Genorise® recombinant mouse GDF-15 protein |
|||
GR124217 | Genorise Scientific | 5 µg | 285 EUR |
Mouse Protein SOX- 15, Sox15 ELISA KIT |
|||
ELI-46188m | Lifescience Market | 96 Tests | 1038 EUR |
FGF-15 Fibroblast Growth Factor-15 Mouse Recombinant Protein |
|||
PROTO35622 | BosterBio | Regular: 10ug | 380.4 EUR |
Description: FGF-15 Protein is 23.78 kDa protein containing 203 amino acid residues including a 10 a.a. N-Terminal His-tag. |
|||
Recombinant Mouse IL-15 Protein, Untagged, E.coli-1mg |
|||
QP5406-1mg | EnQuireBio | 1mg | 4504.8 EUR |
Recombinant Mouse IL-15 Protein, Untagged, E.coli-2ug |
|||
QP5406-2ug | EnQuireBio | 2ug | 163.2 EUR |
Recombinant Mouse IL-15 Protein, Untagged, E.coli-10ug |
|||
QP5406-10ug | EnQuireBio | 10ug | 284.4 EUR |
Recombinant Mouse IL-15 Protein, Untagged, E.coli-100ug |
|||
QP5406-100ug | EnQuireBio | 100ug | 654 EUR |
Recombinant Mouse IL-15 Protein, Untagged, E.coli-500ug |
|||
QP5406-500ug | EnQuireBio | 500ug | 2786.4 EUR |
Recombinant Mouse IL-15RA/IL-15 R alpha Protein |
|||
RP00654 | Abclonal | 10 μg | 174 EUR |
SOX10 Recombinant Protein (Mouse) |
|||
RP174560 | ABM | 100 ug | Ask for price |
Sox11 Recombinant Protein (Mouse) |
|||
RP174563 | ABM | 100 ug | Ask for price |
SOX12 Recombinant Protein (Mouse) |
|||
RP174566 | ABM | 100 ug | Ask for price |
Sox13 Recombinant Protein (Mouse) |
|||
RP174569 | ABM | 100 ug | Ask for price |
Sox14 Recombinant Protein (Mouse) |
|||
RP174572 | ABM | 100 ug | Ask for price |
SOX15 Recombinant Protein (Mouse) |
|||
RP174575 | ABM | 100 ug | Ask for price |
SOX17 Recombinant Protein (Mouse) |
|||
RP174578 | ABM | 100 ug | Ask for price |
SOX18 Recombinant Protein (Mouse) |
|||
RP174581 | ABM | 100 ug | Ask for price |
SOX21 Recombinant Protein (Mouse) |
|||
RP174587 | ABM | 100 ug | Ask for price |
SOX30 Recombinant Protein (Mouse) |
|||
RP174593 | ABM | 100 ug | Ask for price |
IL-15 Recombinant Protein |
|||
11-331 | ProSci | 0.05 mg | 714.3 EUR |
Description: Interleukin 15 is also known as IL15, IL-15, and is a cytokine with structural similarity to IL-2. Like IL-2, IL-15 binds to and signals through the IL-2/IL-15 beta chain (CD122) and the common gamma chain (gamma-C, CD132). IL-15 is secreted by mononuclear phagocytes (and some other cells) following infection by virus(es). This cytokine induces cell proliferation of natural killer cells; cells of the innate immune system whose principal role is to kill virally infected cells. Interleukin 15 (IL-15) regulates T and natural killer (NK) cell activation and proliferation. Survival signals that maintain memory T cells in the absence of antigen are provided by IL-15. This cytokine is also implicated in NK cell development. In rodent lymphocytes, IL-15 prevents apoptosis by inducing an apoptosis inhibitor, BCL2L1/BCL-x(L). IL-15 has been shown to enhance the anti-tumor immunity of CD8+ T cells in pre-clinical models. A phase I clinical trial to evaluate the safety, dosing, and anti-tumor efficacy of IL-15 in patients with metastatic melanoma and renal cell carcinoma (kidney cancer) has begun to enroll patients at the National Institutes of Health. |
|||
IL-15 Recombinant Protein |
|||
11-386 | ProSci | 0.05 mg | 852.9 EUR |
Description: Interleukin 15 is also known as IL15, IL-15, and is a cytokine with structural similarity to IL-2. Like IL-2, IL-15 binds to and signals through the IL-2/IL-15 beta chain (CD122) and the common gamma chain (gamma-C, CD132). IL-15 is secreted by mononuclear phagocytes (and some other cells) following infection by virus(es). This cytokine induces cell proliferation of natural killer cells; cells of the innate immune system whose principal role is to kill virally infected cells. Interleukin 15 (IL-15) regulates T and natural killer (NK) cell activation and proliferation. Survival signals that maintain memory T cells in the absence of antigen are provided by IL-15. This cytokine is also implicated in NK cell development. In rodent lymphocytes, IL-15 prevents apoptosis by inducing an apoptosis inhibitor, BCL2L1/BCL-x(L). IL-15 has been shown to enhance the anti-tumor immunity of CD8+ T cells in pre-clinical models. A phase I clinical trial to evaluate the safety, dosing, and anti-tumor efficacy of IL-15 in patients with metastatic melanoma and renal cell carcinoma (kidney cancer) has begun to enroll patients at the National Institutes of Health. |
|||
IL-15 Recombinant Protein |
|||
91-013 | ProSci | 0.05 mg | 821.4 EUR |
Description: Human Interleukin 15 (IL-15) is a cytokine that regulates T cell and natural killer cell activation and proliferation. IL-15 binds to the alpha subunit of the IL15 receptor (IL-15RA) with high affinity. IL-15 also binds to the beta and gamma chains of the IL-2 receptor, but not the alpha subunit of the IL2 receptor. IL-15 is structurally and functionally related to IL-2. Both cytokines share some subunits of receptors, allowing them to compete for and negatively regulate each other's activity. The number of CD8+ memory T cells is controlled by a balance between IL-15 and IL-2. Despite their many overlapping functional properties, IL-2 and IL-15 are, in fact, quite distinct players in the immune system. IL-15 is constitutively expressed by a wide variety of cell types and tissues, including monocytes, macrophages and DCs. Mature Human IL-15 shares 70% amino acid sequence identity with Mouse and Rat IL-15. |
|||
IL-15 Recombinant Protein |
|||
40-260-0002mg | ProSci | 0.002 mg | 311.1 EUR |
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant human IL-15 is a 12.9 kDa protein consisting of 114 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
40-260-001mg | ProSci | 0.01 mg | 437.1 EUR |
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant human IL-15 is a 12.9 kDa protein consisting of 114 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
40-422-0002mg | ProSci | 0.002 mg | 311.1 EUR |
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant murine IL-15 is a 13.3 kDa protein consisting of 115 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
40-422-001mg | ProSci | 0.01 mg | 437.1 EUR |
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant murine IL-15 is a 13.3 kDa protein consisting of 115 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
40-476-0002mg | ProSci | 0.002 mg | 311.1 EUR |
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant rat IL-15 is a 13.5 kDa protein consisting of 115 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
40-476-001mg | ProSci | 0.01 mg | 437.1 EUR |
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant rat IL-15 is a 13.5 kDa protein consisting of 115 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
40-558 | ProSci | 0.01 mg | 481.2 EUR |
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activities primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant human IL-15 is a 12.9 kDa protein consisting of 115 amino acid residues. |
|||
SOX1 Recombinant Protein (Mouse) |
|||
RP174557 | ABM | 100 ug | Ask for price |
Sox3 Recombinant Protein (Mouse) |
|||
RP174590 | ABM | 100 ug | Ask for price |
Sox4 Recombinant Protein (Mouse) |
|||
RP174596 | ABM | 100 ug | Ask for price |
SOX5 Recombinant Protein (Mouse) |
|||
RP174599 | ABM | 100 ug | Ask for price |
SOX5 Recombinant Protein (Mouse) |
|||
RP174602 | ABM | 100 ug | Ask for price |
SOX5 Recombinant Protein (Mouse) |
|||
RP174605 | ABM | 100 ug | Ask for price |
Sox6 Recombinant Protein (Mouse) |
|||
RP174608 | ABM | 100 ug | Ask for price |
Sox6 Recombinant Protein (Mouse) |
|||
RP174611 | ABM | 100 ug | Ask for price |
Sox6 Recombinant Protein (Mouse) |
|||
RP174614 | ABM | 100 ug | Ask for price |
SOX7 Recombinant Protein (Mouse) |
|||
RP174617 | ABM | 100 ug | Ask for price |
Sox8 Recombinant Protein (Mouse) |
|||
RP174620 | ABM | 100 ug | Ask for price |
SOX9 Recombinant Protein (Mouse) |
|||
RP174623 | ABM | 100 ug | Ask for price |
15-PGDH Recombinant Protein |
|||
91-661 | ProSci | 0.05 mg | 852.9 EUR |
Description: 15-hydroxyprostaglandin dehydrogenase [NAD(+)], also known as Prostaglandin dehydrogenase 1, 15-PGDH, HPGD and PGDH1, belongs to the short-chain dehydrogenases/reductases (SDR) family. HPGD localizes to the cytoplasm and can be found in colon epithelium, existing as a homodimer. HPGD catalyzes the NAD-dependent dehydrogenation of lipoxin A4 to form 15-oxo-lipoxin A4. HPGD is down-regulated by cortisol, dexamethasone and betamethasone, up-regulated by TGFB1. HPGD inhibits in vivo proliferation of colon cancer cells. HPGD is the key enzyme for the inactivation of prostaglandins, and thus regulates processes such as inflammation or proliferation. |
|||
Mucin-15 Recombinant Protein |
|||
91-727 | ProSci | 0.05 mg | 821.4 EUR |
Description: Mucin-15 is a single-pass type I membrane protein member of the Mucin family. Mucins are a family of high molecular weight, heavily glycosylated proteins (glycoconjugates) produced by epithelial tissues in most metazoans. A key characteristic of Mucins is their ability to form gels. Therefore they are a key component in most gel-like secretions, serving functions from lubrication to cell signalling to forming chemical barriers. Mucin-15 is expressed in many tissues. Mucin-15 is highly glycosylated (N- and O-linked carbohydrates). Mucin-15 may play a role in the cell adhesion to the extracellular matrix. |
|||
Recombinant Mouse Interleukin-15 |
|||
7-00973 | CHI Scientific | 2µg | Ask for price |
Recombinant Mouse Interleukin-15 |
|||
7-00974 | CHI Scientific | 10µg | Ask for price |
Recombinant Mouse Interleukin-15 |
|||
7-00975 | CHI Scientific | 1mg | Ask for price |
IL-15 Interleukin-15 Rat Recombinant Protein |
|||
PROTP97604 | BosterBio | Regular: 10ug | 380.4 EUR |
Description: Interleukin-15 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 115 amino acids and having a molecular mass of 13533 Dalton. ;The IL-15 is purified by proprietary chromatographic techniques. |
|||
IL-15 Interleukin-15 Human Recombinant Protein |
|||
PROTP40933 | BosterBio | Regular: 10ug | 380.4 EUR |
Description: Interleukin-15 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 114 amino acids (and an N-terminal Methionine) and having a molecular mass of 12.8kDa. The IL-15 is purified by proprietary chromatographic techniques. |
|||
HPGD Hydroxyprostaglandin Dehydrogenase 15-(NAD) Mouse Recombinant Protein |
|||
PROTQ8VCC1 | BosterBio | Regular: 20ug | 380.4 EUR |
Description: HPGD Mouse Recombinant produced in E. coli is a single polypeptide chain containing 292 amino acids (1-269) and having a molecular mass of 31.6kDa. ;HPGD is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.   |
|||
Recombinant Rat IL-15 Protein |
|||
PROTP97604-1 | BosterBio | 10ug | 380.4 EUR |
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant rat IL-15 is a 13.5 kDa protein consisting of 115 amino acid residues. |
|||
Recombinant HPV-15 E1 Protein |
|||
VAng-Wyb3028-inquire | Creative Biolabs | inquire | Ask for price |
Description: Human papillomavirus type 15 Replication protein E1, recombinant protein. |
|||
Recombinant HPV-15 L2 Protein |
|||
VAng-Wyb3032-inquire | Creative Biolabs | inquire | Ask for price |
Description: Human papillomavirus type 15 Minor capsid protein L2, recombinant protein. |
|||
GDF15 Growth and Differentiation factor 15 Mouse Recombinant Protein |
|||
PROTQ9Z0J7 | BosterBio | Regular: 20ug | 380.4 EUR |
Description: GDF15 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 138 amino acids (189-303 a.a) and having a molecular mass of 14.9kDa. GDF15 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
Recombinant Human IL-15 Protein |
|||
PROTP40933-3 | BosterBio | 10ug | 380.4 EUR |
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowel disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant human IL-15 is a 12.9 kDa protein consisting of 114 amino acid residues. |
|||
IL-15, human recombinant protein |
|||
P1029-.01 | ApexBio | 10 µg | 360 EUR |
Description: Interleukin 15 (IL-15) is an immunomodulating cytokine mainly produced by adherent peripheral blood mononuclear cells, fibroblasts and epithelial cells and stimulates the proliferation of T lymphocytes. |
|||
IL-15, human recombinant protein |
|||
P1029-.05 | ApexBio | 50 µg | 1052.4 EUR |
Description: Interleukin 15 (IL-15) is an immunomodulating cytokine mainly produced by adherent peripheral blood mononuclear cells, fibroblasts and epithelial cells and stimulates the proliferation of T lymphocytes. |
|||
IL-15, human recombinant protein |
|||
P1029-1 | ApexBio | 1 mg | 6406.8 EUR |
Description: Interleukin 15 (IL-15) is an immunomodulating cytokine mainly produced by adherent peripheral blood mononuclear cells, fibroblasts and epithelial cells and stimulates the proliferation of T lymphocytes. |
|||
Swine IL-15 Recombinant Protein |
|||
R00212-3 | BosterBio | 5ug/vial | 310.8 EUR |
Description: Interleukin-15 (IL-15) is a cytokine with structural similarity to IL-2 that is secreted by mononuclear phagocytes following infection by virus(es). This cytokine induces cell proliferation of natural killer cells. Swine IL-15 Recombinant Protein is purified interleukin-15 produced in yeast. |
|||
Recombinant Human IL-15 Protein |
|||
RP00393 | Abclonal | 10 μg | 265.2 EUR |
Recombinant human IL-15 Protein |
|||
RP01236 | Abclonal | 10 μg | 231.6 EUR |
IL-15 mutant Recombinant Protein |
|||
90-504 | ProSci | 50 ug | 714.3 EUR |
Description: Interleukin-15 (IL-15) has a broad spectrum of biological activities. It is crucial for the development, proliferation, survival and differentiation of multiple cells from both innate and adaptive immune systems. IL-15 up-regulation has a central role in the development of several autoimmune or chronic inflammatory disorders. Targeting IL-15 or its receptor may have a valuable impact on the treatment of immune-mediated diseases. IL-15 participates in the development of important immune antitumor mechanisms. It activates CD8(+) T cells, natural killer (NK) cells, NK T cells, and can promote the formation of antitumor antibodies. IL-15 can also protect T effector cells from the action of T regulatory cells and reverse tolerance to tumor-associated antigens. In pre-clinical studies IL-15 has been found to demonstrate potentiated antitumor effects following pre-association with IL-15Ralpha, or when used in combination with chemotherapy, adoptive therapy, monoclonal antibodies, and tumor vaccines. |
|||
Recombinant Murine IL-15 Protein |
|||
PROTP48346-2 | BosterBio | 10ug | 380.4 EUR |
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant murine IL-15 is a 13.3 kDa protein consisting of 115 amino acid residues. |
|||
Bovine IL-15 Recombinant Protein |
|||
R00212 | BosterBio | 5ug/vial | 310.8 EUR |
Description: Interleukin-15 (IL-15) is a cytokine with structural similarity to IL-2 that is secreted by mononuclear phagocytes following infection by virus(es). This cytokine induces cell proliferation of natural killer cells. Bovine IL-15 Recombinant Protein is purified interleukin-15 produced in yeast. |
|||
Equine IL-15 Recombinant Protein |
|||
R00212-1 | BosterBio | 5ug/vial | 310.8 EUR |
Description: Interleukin-15 (IL-15) is a cytokine with structural similarity to IL-2 that is secreted by mononuclear phagocytes following infection by virus(es). This cytokine induces cell proliferation of natural killer cells. Equine IL-15 Recombinant Protein is purified interleukin-15 produced in yeast. |
|||
Recombinant Human Transcription factor SOX-2 Protein, His-SUMO, E.coli-10ug |
|||
QP6718-ec-10ug | EnQuireBio | 10ug | 240 EUR |
Recombinant Human Transcription factor SOX-2 Protein, His-SUMO, E.coli-1mg |
|||
QP6718-ec-1mg | EnQuireBio | 1mg | 1958.4 EUR |
Recombinant Human Transcription factor SOX-2 Protein, His-SUMO, E.coli-50ug |
|||
QP6718-ec-50ug | EnQuireBio | 50ug | 315.6 EUR |
IL-15 R alpha & IL-15 fusion protein Recombinant Protein |
|||
92-588 | ProSci | 0.05 mg | 651.3 EUR |
Description: Interleukin-15 receptor subunit alpha, also known as Il15ra, is a high-affinity receptor for interleukin-15. Il15ra associates as a heterotrimer with the IL-2 receptor beta and gamma subunits (Common gamma chain, or gamma c) to initiate signal transduction. It can signal both in cis and trans where IL15R from one subset of cells presents IL15 to neighboring IL2RG-expressing cells. Il15ra is expressed in special cells including a wide variety of Tand B cells and non-lymphoid cells. Human Il15ra shares 45% amino acid sequence homology with the mouse form of the receptor. Eight isoforms of IL-15 R alpha mRNA have been identified, resulting from alternative splicing events involving different exons.Interleukin 15 (IL-15) is a cytokine that regulates T cell and natural killer cell activation and proliferation. IL-15 binds to the alpha subunit of the IL15 receptor (IL-15RA) with high affinity. IL-15 also binds to the beta and gamma chains of the IL-2 receptor, but not the alpha subunit of the IL2 receptor. IL-15 is structurally and functionally related to IL-2. Both cytokines share some subunits of receptors, allowing them to compete for and negatively regulate each other's activity. The number of CD8+ memory T cells is controlled by a balance between IL-15 and IL-2. Despite their many overlapping functional properties, IL-2 and IL-15 are, in fact, quite distinct players in the immune system. IL-15 is constitutively expressed by a wide variety of cell types and tissues, including monocytes, macrophages and DCs. |
|||
Recombinant Human Transcription factor SOX-2 Protein, His-SUMO, E.coli-100ug |
|||
QP6718-ec-100ug | EnQuireBio | 100ug | 489.6 EUR |
Recombinant Human Transcription factor SOX-2 Protein, His-SUMO, E.coli-200ug |
|||
QP6718-ec-200ug | EnQuireBio | 200ug | 760.8 EUR |
Recombinant Human Transcription factor SOX-2 Protein, His-SUMO, E.coli-500ug |
|||
QP6718-ec-500ug | EnQuireBio | 500ug | 1272 EUR |
Recombinant human Transcription factor SOX-10 |
|||
P1489 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human Transcription factor SOX-10 |
|||
Recombinant human Transcription factor SOX-13 |
|||
P1789 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human Transcription factor SOX-13 |
|||
Recombinant human Transcription factor SOX-12 |
|||
P2617 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human Transcription factor SOX-12 |
|||
Recombinant human Transcription factor SOX-21 |
|||
P2827 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human Transcription factor SOX-21 |
|||
IGHV3OR16-15 Recombinant Protein (Human) |
|||
RP064674 | ABM | 100 ug | Ask for price |
Recombinant Mouse Fibroblast growth factor 15 Protein, His-SUMO, E.coli-1mg |
|||
QP7474-ec-1mg | EnQuireBio | 1mg | 2763.6 EUR |
Recombinant human Transcription factor SOX-7 |
|||
P1745 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human Transcription factor SOX-7 |
|||
Recombinant Mouse Fibroblast growth factor 15 Protein, His-SUMO, E.coli-100ug |
|||
QP7474-ec-100ug | EnQuireBio | 100ug | 685.2 EUR |
Recombinant Mouse Fibroblast growth factor 15 Protein, His-SUMO, E.coli-10ug |
|||
QP7474-ec-10ug | EnQuireBio | 10ug | 326.4 EUR |
Recombinant Mouse Fibroblast growth factor 15 Protein, His-SUMO, E.coli-200ug |
|||
QP7474-ec-200ug | EnQuireBio | 200ug | 1077.6 EUR |
Recombinant Mouse Fibroblast growth factor 15 Protein, His-SUMO, E.coli-500ug |
|||
QP7474-ec-500ug | EnQuireBio | 500ug | 1816.8 EUR |
Recombinant Mouse Fibroblast growth factor 15 Protein, His-SUMO, E.coli-50ug |
|||
QP7474-ec-50ug | EnQuireBio | 50ug | 434.4 EUR |
GDF-15 / MIC-1 Recombinant Protein |
|||
11-261 | ProSci | 0.1 mg | 714.3 EUR |
Description: Growth Differentiation Factor 15 (GDF-15), also called Macrophage Inhibitory Cytokine 1 (MIC-1). Expression of MIC-1 mRNA in monocytoid cells is up-regulated by a variety of stimuli associated with activation, including interleukin 1β, tumor necrosis factor α (TNF-α), interleukin 2, and macrophage colony-stimulating factor but not interferon γ, or lipopolysaccharide (LPS). It is highly expressed in cardiomyocytes, adipocytes, macrophages, endothelial cells, and vascular smooth muscle cells in normal and pathological condition. GDF-15 increases during tissue injury and inflammatory states and is associated with cardiometabolic risk. Increased GDF-15 levels are associated with cardiovascular diseases such as hypertrophy, heart failure, atherosclerosis, endothelial dysfunction, obesity, insulin resistance, diabetes, and chronic kidney diseases in diabetes. Increased GDF-15 level is linked with the progression and prognosis of the disease condition. |
|||
IL-15 R alpha Recombinant Protein |
|||
92-484 | ProSci | 0.05 mg | 374.1 EUR |
Description: Mouse interleukin-15 receptor subunit alpha, also known as Il15ra, is a high-affinity receptor for interleukin-15. Il15ra associates as a heterotrimer with the IL-2 receptor beta and gamma subunits (Common gamma chain, or gamma c) to initiate signal transduction. It can signal both in cis and trans where IL15R from one subset of cells presents IL15 to neighboring IL2RG-expressing cells. Il15ra is expressed in special cells including a wide variety of Tand B cells and non-lymphoid cells. Human Il15ra shares 45% amino acid sequence homology with the mouse form of the receptor. Eight isoforms of IL-15 R alpha mRNA have been identified, resulting from alternative splicing events involving different exons. |
|||
IL-15 R alpha Recombinant Protein |
|||
92-530 | ProSci | 0.05 mg | 739.5 EUR |
Description: Interleukin 15 Receptor alpha (IL-15R alpha) is a transmembrane glycoprotein that plays a pleiotropic role in immune development and function, including the positive maintenance of lymphocyte homeostasis. IL-15R alpha chain can bind soluble IL-15 and “transpresent” cytokine to the cells, allowing them to respond to IL-15. Soluble IL-15R alpha can function as a specific high-affinity IL-15 antagonist. The soluble IL-15/IL-15R alpha complexes exhibit a strong agonistic activity which is mediated through membrane-bound IL-15 receptor beta and gamma heterodimers and enables signaling to cells. |
|||
GDF-15/MIC-1 Recombinant Protein |
|||
40-645 | ProSci | 5 ug | 311.1 EUR |
Description: GDF-15 belongs to the TGF-β cytokine family, whose members play an important role during prenatal development and postnatal growth, and the remodeling and maintenance of a variety of tissues and organs. GDF-15 is expressed predominantly in the placenta and, to a much lesser extent, in various other tissues. The presence of GDF-15 in amniotic fluid and its elevated levels in the sera of pregnant women suggest GDF-15's involvement in gestation and embryonic development. GDF-15 generally exerts tumor suppressive activities and is one of the predominant factors produced and secreted in response to activation of the p53 pathway. Interestingly, the serum level of GDF-15 is positively correlated with neoplastic progression of several tumor types, including certain colorectal, pancreatic, and prostate cancers. Human GDF-15/MIC-1 is a disulfide linked homodimeric protein consisting of two 112 amino acid polypeptide chains. The calculated molecular weight of Human GDF-15/MIC-1 is 24.6 kDa. |
|||
GDF-15/MIC-1 Recombinant Protein |
|||
40-646 | ProSci | 5 ug | 311.1 EUR |
Description: GDF-15 belongs to the TGF-β cytokine family, whose members play an important role during prenatal development and postnatal growth, and the remodeling and maintenance of a variety of tissues and organs. GDF-15 is expressed predominantly in the placenta and, to a much lesser extent, in various other tissues. The presence of GDF-15 in amniotic fluid and its elevated levels in the sera of pregnant women suggest GDF-15's involvement in gestation and embryonic development. GDF-15 generally exerts tumor suppressive activities and is one of the predominant factors produced and secreted in response to activation of the p53 pathway. Interestingly, the serum level of GDF-15 is positively correlated with neoplastic progression of several tumor types, including certain colorectal, pancreatic, and prostate cancers. Recombinant Human GDF-15/MIC-1 is a disulfide linked homodimeric protein consisting of two 112 amino acid polypeptide chains. The calculated molecular weight of Recombinant Human GDF-15/MIC-1 is 24.6 kDa. |
|||
IL-15 Interleukin-15 Human Recombinant Protein, His Tag |
|||
PROTP40933-1 | BosterBio | Regular: 10ug | 380.4 EUR |
Description: Interleukin-15 His Human Recombinant ?produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing 123 amino acids fragment (49-162) having a total molecular weight of 13.9 kDa with an C-terminal hexahistidine tag. _x000D_ The IL-15 His is purified by proprietary chromatographic techniques. _x000D_ _x000D_ |
|||
Guinea Pig IL-15 Recombinant Protein |
|||
R00212-2 | BosterBio | 5ug/vial | 310.8 EUR |
Description: Interleukin-15 (IL-15) is a cytokine with structural similarity to IL-2 that is secreted by mononuclear phagocytes following infection by virus(es). This cytokine induces cell proliferation of natural killer cells. Guinea Pig IL-15 Recombinant Protein is purified interleukin-15 produced in yeast. |
|||
IL-15 mutant Recombinant Protein (biotin) |
|||
90-505 | ProSci | 1 Vial | 714.3 EUR |
Description: Interleukin-15 (IL-15) has a broad spectrum of biological activities. It is crucial for the development, proliferation, survival and differentiation of multiple cells from both innate and adaptive immune systems. IL-15 up-regulation has a central role in the development of several autoimmune or chronic inflammatory disorders. Targeting IL-15 or its receptor may have a valuable impact on the treatment of immune-mediated diseases. IL-15 participates in the development of important immune antitumor mechanisms. It activates CD8(+) T cells, natural killer (NK) cells, NK T cells, and can promote the formation of antitumor antibodies. IL-15 can also protect T effector cells from the action of T regulatory cells and reverse tolerance to tumor-associated antigens. In pre-clinical studies IL-15 has been found to demonstrate potentiated antitumor effects following pre-association with IL-15Ralpha, or when used in combination with chemotherapy, adoptive therapy, monoclonal antibodies, and tumor vaccines. _x000D_Application: Useful for immunofluorescent staining and flow cytometric analysis to identify and enumerate IL-15Ralpha expressing cells within mixed cell populations. |
|||
Recombinant Mouse Interleukin-15, His Tag |
|||
7-00976 | CHI Scientific | 2µg | Ask for price |
Recombinant Mouse Interleukin-15, His Tag |
|||
7-00977 | CHI Scientific | 10µg | Ask for price |
Recombinant Mouse Interleukin-15, His Tag |
|||
7-00978 | CHI Scientific | 1mg | Ask for price |
Recombinant human Siglec-15/CD33L3 Protein |
|||
RP01187 | Abclonal | 5 μg | 163.2 EUR |
Recombinant Mouse Fibroblast Growth Factor-15 |
|||
7-00370 | CHI Scientific | 2µg | Ask for price |
Recombinant Mouse Fibroblast Growth Factor-15 |
|||
7-00371 | CHI Scientific | 10µg | Ask for price |
Recombinant Mouse Fibroblast Growth Factor-15 |
|||
7-00372 | CHI Scientific | 1mg | Ask for price |
KLK15 Kallikrein-15 Human Recombinant Protein |
|||
PROTQ9H2R5 | BosterBio | Regular: 20ug | 380.4 EUR |
Description: KLK15 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 258 amino acids (22-256a.a) and having a molecular mass of 28.2kDa. ;KLK15 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
Recombinant Bone Morphogenetic Protein 15 (BMP15) |
|||
4-RPC107Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Bone Morphogenetic Protein 15 expressed in: E.coli |
|||
Recombinant Bone Morphogenetic Protein 15 (BMP15) |
|||
4-RPC107Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Bone Morphogenetic Protein 15 expressed in: E.coli |
|||
Recombinant Bone Morphogenetic Protein 15 (BMP15) |
|||
4-RPC107Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Bone Morphogenetic Protein 15 expressed in: E.coli |
|||
TAGAP Recombinant Protein (Mouse) (Recombinant- Tag) |
|||
RP177155 | ABM | 100 ug | Ask for price |
TAGLN Recombinant Protein (Mouse) (Recombinant- Tag) |
|||
RP177161 | ABM | 100 ug | Ask for price |
Human CellExp? Siglec-15, Mouse Recombinant |
|||
P1466-10 | Biovision | each | 196.8 EUR |
Human CellExp? Siglec-15, Mouse Recombinant |
|||
P1466-50 | Biovision | each | 574.8 EUR |
Recombinant Mouse EGF Protein |
|||
RP00628 | Abclonal | 10 μg | 147.6 EUR |
Recombinant Mouse SCF Protein |
|||
RP01055 | Abclonal | 10 μg | 242.4 EUR |
Recombinant Mouse LIF Protein |
|||
R01400-1 | BosterBio | 100ug/vial | 352.8 EUR |
Recombinant Human Adiponectin Protein (aa 15-244) |
|||
VAng-2895Lsx-100g | Creative Biolabs | 100 µg | 1297.2 EUR |
Description: Recombinant Human Adiponectin is expressed in E. coli. (Uniprot ID: Q15848) |
|||
Recombinant Human Adiponectin Protein (aa 15-244) |
|||
VAng-2895Lsx-500g | Creative Biolabs | 500 µg | 3112.8 EUR |
Description: Recombinant Human Adiponectin is expressed in E. coli. (Uniprot ID: Q15848) |
|||
IL-15 R alpha / CD215 Recombinant Protein |
|||
11-365 | ProSci | 0.1 mg | 651.3 EUR |
Description: IL15R is a heterotrimer of IL15RA, IL2RB and IL2RG. IL-15RA, also known as CD215, IL-15 R alpha, is a widely expressed 60 kDa transmembrane glycoprotein. High-affinity receptor for interleukin-15. Can signal both in cis and trans where IL15R from one subset of cells presents IL15 to neighboring IL2RG-expressing cells. Expression of different isoforms may alter or interfere with signal transduction. An interleukin (IL)-15 superagonist/IL-15 receptor α fusion complex (IL-15SA/IL-15RA; ALT-803) activates the IL-15 receptor on CD8 T cells and NK cells, and has shown significant anti-tumor. Signal transduction involves SYK. Higher levels of soluble sIL-15RA form in comparison with membrane-bound forms is present in all brain structures. |
|||
Interferon-stimulated Gene 15 Recombinant Protein |
|||
92-169 | ProSci | 0.05 mg | 437.1 EUR |
Description: Ubiquitin-Like Protein ISG15 (ISG15) is a ubiquitin-like protein that becomes conjugated to many cellular proteins upon activation by interferon-alpha and -beta. Several functions have been ascribed to the encoded protein, including chemotactic activity towards neutrophils, direction of ligated target proteins to intermediate filaments, cell-to-cell signaling, and antiviral activity during viral infections. While conjugates of this protein have been found to be noncovalently attached to intermediate filaments, this protein is sometimes secreted. ISG15 becomes conjugated to a diverse set of proteins after IFN-alpha/beta stimulation or microbial challenge. The functions or biochemical consequences ISG15 conjugation to proteins are not yet known, but it appears that this modification does not target proteins for proteasomal degradation. ISG15 shows specific chemotactic activity towards neutrophils and activates them to induce release of eosinophil chemotactic factors. Upon interferon treatment, ISG15 can be detected in both free and conjugated forms, and is secreted from monocytes and lymphocytes where it can function as a cytokine. In the cell, ISG15 co-localizes with intermediate filaments and ISGylation may modulate the JAK-STAT pathway or certain aspects of neurological disease. |
|||
CTAGE5 Recombinant Protein (Mouse) (Recombinant- Tag) |
|||
RP126449 | ABM | 100 ug | Ask for price |
CTAGE5 Recombinant Protein (Mouse) (Recombinant- Tag) |
|||
RP126452 | ABM | 100 ug | Ask for price |
CTAGE5 Recombinant Protein (Mouse) (Recombinant- Tag) |
|||
RP126455 | ABM | 100 ug | Ask for price |
Tagap1 Recombinant Protein (Mouse) (Recombinant Tag) |
|||
RP177158 | ABM | 100 ug | Ask for price |
TAGLN2 Recombinant Protein (Mouse) (Recombinant Tag) |
|||
RP177164 | ABM | 100 ug | Ask for price |
TAGLN3 Recombinant Protein (Mouse) (Recombinant Tag) |
|||
RP177167 | ABM | 100 ug | Ask for price |
Genorise® Recombinant rat IL-15 Protein |
|||
GR125018 | Genorise Scientific | 5 µg | 285 EUR |
Recombinant Mouse C1s1 Protein |
|||
CTP-031 | Creative Biolabs | 100ug | Ask for price |
Description: A recombinant mouse C1s1 protein with a N-terminal tag or C-terminal tag expressed in E. coli, yeast, insect, or mammalian cells. |
|||
Recombinant Mouse C1s2 Protein |
|||
CTP-032 | Creative Biolabs | 100ug | Ask for price |
Description: A recombinant mouse C1s2 protein with a N-terminal tag or C-terminal tag expressed in E. coli, yeast, insect, or mammalian cells. |
|||
Recombinant Mouse C4bp Protein |
|||
CTP-063 | Creative Biolabs | 100ug | Ask for price |
Description: A recombinant mouse C4bp protein with a N-terminal tag or C-terminal tag expressed in E. Coli, yeast, insect, or mammalian cell. |
|||
Recombinant Mouse FGF2 Protein |
|||
R00121-1 | BosterBio | 100ug/vial | 352.8 EUR |
Recombinant Mouse CD28 Protein |
|||
RP01211 | Abclonal | 10 μg | 188.4 EUR |
Recombinant Mouse FGF7 Protein |
|||
R01931-1 | BosterBio | 100ug/vial | 352.8 EUR |
Genorise® Recombinant rat GDF-15 Protein |
|||
GR125012 | Genorise Scientific | 5 µg | 285 EUR |
Recombinant Mouse C1ql1 Protein |
|||
CTP-018 | Creative Biolabs | 100ug | Ask for price |
Description: A recombinant mouse C1ql1 protein with a N-terminal tag or C-terminal tag expressed inE. Coli, yeast, insect, or mammalian cell. |
|||
Recombinant Mouse EphB2 Protein |
|||
RP01156 | Abclonal | 10 μg | 186 EUR |
Recombinant Mouse EphB2 Protein |
|||
RP01191 | Abclonal | 10 μg | 178.8 EUR |
Recombinant Mouse PCSK9 Protein |
|||
RP01200 | Abclonal | 10 μg | 242.4 EUR |
Astrocytic Phosphoprotein PEA-15 Recombinant Protein |
|||
92-118 | ProSci | 0.05 mg | 651.3 EUR |
Description: Astrocyticphosphoprotein PEA-15 (PEA15) is a death effector domain (DED)-containing protein. PEA15 is mainly expressed in the central nervous system, principally in astrocytes. Increased PEA15 levels affect tumorigenesis and cancer progression. PEA15 is overexpressed in breast cancers and gliomas as well as in type 2 diabetes. PEA15 blocks Ras-mediated inhibition of integrin activation and modulates the ERK MAP kinase cascade. PEA15 also inhibits RPS6KA3 activities by holding it in the cytoplasm. In addition, PEA15 inhibits both TNFRSF6 and TNFRSF1A mediated CASP8 activity and apoptosis. At present, PEA15 expression is also a significant prognostic marker in ovarian cancer. |
|||
Recombinant HAdV-15 PIV Protein (aa 1-367) |
|||
VAng-Cr4231-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 5438.4 EUR |
Description: HAdV-15 Fiber protein (PIV), recombinant protein. |
|||
Recombinant HAdV-15 PIV Protein (aa 1-367) |
|||
VAng-Cr4231-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 3837.6 EUR |
Description: HAdV-15 Fiber protein (PIV), recombinant protein. |
|||
Recombinant HAdV-15 PIV Protein (aa 1-367) |
|||
VAng-Cr4231-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 2617.2 EUR |
Description: HAdV-15 Fiber protein (PIV), recombinant protein. |
|||
Recombinant Mouse CXCL16 Protein |
|||
RP01061 | Abclonal | 10 μg | 242.4 EUR |
Recombinant HPV-15 E2 (aa 1-382) Protein |
|||
VAng-Wyb3029-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 5553.6 EUR |
Description: Human papillomavirus type 15 Regulatory protein E2, recombinant protein. |
|||
Recombinant HPV-15 E2 (aa 1-382) Protein |
|||
VAng-Wyb3029-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 3921.6 EUR |
Description: Human papillomavirus type 15 Regulatory protein E2, recombinant protein. |
|||
Recombinant HPV-15 E2 (aa 1-382) Protein |
|||
VAng-Wyb3029-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 2683.2 EUR |
Description: Human papillomavirus type 15 Regulatory protein E2, recombinant protein. |
|||
Recombinant HPV-15 E6 (aa 1-149) Protein |
|||
VAng-Wyb3030-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 3723.6 EUR |
Description: Human papillomavirus type 15 protein E6, recombinant protein. |
|||
Recombinant HPV-15 E6 (aa 1-149) Protein |
|||
VAng-Wyb3030-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 2667.6 EUR |
Description: Human papillomavirus type 15 protein E6, recombinant protein. |
|||
Recombinant HPV-15 E6 (aa 1-149) Protein |
|||
VAng-Wyb3030-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 1842 EUR |
Description: Human papillomavirus type 15 protein E6, recombinant protein. |
|||
Genorise® Recombinant Feline IL-15 protein |
|||
GR186047 | Genorise Scientific | 5 mg | 285 EUR |
Recombinant HPV-15 E7 (aa 1-93) Protein |
|||
VAng-Wyb3031-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 3360 EUR |
Description: Human papillomavirus type 15 protein E7, recombinant protein. |
|||
Recombinant HPV-15 E7 (aa 1-93) Protein |
|||
VAng-Wyb3031-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 2403.6 EUR |
Description: Human papillomavirus type 15 protein E7, recombinant protein. |
Stronger promotion results of the EA PM on bacterial manufacturing and neighborhood shift from oligotrophs to copiotrophs was demonstrated at the extra oligotrophic websites with decrease chlorophyll a concentrations. These outcomes recommend that PM deposition from polluted areas has the potential to change the typical oligotrophic microbiomes and alter the web metabolic steadiness of the bacterial neighborhood. These will then affect the dynamics of carbon circulate in microbial meals webs and biogeochemical cycles, particularly with the pattern of world warming and enlargement of low-chlorophyll areas.